Neuroscience – LBT-3627

Click to read Longevity Biotech is currently developing LBT-3627 as a novel neuroprotective agent as a possible treatment for disorders such as Parkinson’s Disease. LBT-3627 is a Hybridtide® that targets the VIP family of receptors … Read More